Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
The Journal of Medicine and Philosophy|November 8, 2014
Reframing the disease debate and defending the biostatistical theoryPeter H SchwartzThe Journal of Medicine and Philosophy|September 2, 2017
Progress in Defining Disease: Improved Approaches and Increased ImpactPeter H SchwartzTheoretical Medicine and Bioethics|June 25, 2009
Disclosure and rationality: comparative risk information and decision-making about preventionPeter H SchwartzMolecular Genetics & Genomic Medicine|April 25, 2020
Patient perspectives on variant reclassification after cancer susceptibility testingColin M E Halverson, Laurie M Connors, Bronson C Wessinger, et al.Orphanet Journal of Rare Diseases|March 15, 2024
Patient interest in the development of a center for Ehlers-Danlos syndrome/hypermobility spectrum disorder in the Chicagoland regionWendy Wagner, Tom A Doyle, Clair A Francomano, et al.American Journal of Nephrology|May 26, 2016
Living Kidney Donors Who Develop Kidney Failure: Excerpts of Their ThoughtsColin M E Halverson, Jackie Y Wang, Michael Poulson, et al.Applied & Translational Genomics|March 4, 2016
Patients' views on incidental findings from clinical exome sequencingKristin E Clift, Colin M E Halverson, Alexander S Fiksdal, et al.Journal of General Internal Medicine|April 19, 2008
The ethics of information: absolute risk reduction and patient understanding of screeningPeter H Schwartz, Eric M MeslinThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 1, 2023
Selling Clinical Biospecimens: Guidance for Researchers and Private IndustryPeter H Schwartz, Jane A HartsockPageof 6